You are here

  • Home
  • Archive
  • Volume 75, Issue 6
  • Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study

Article info

Article menu

Download PDFPDF

Original research
Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study
Free

Authors

  • Brandon Michael Henry Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA PubMed articlesGoogle scholar articles
  • Isaac Cheruiyot School of Medicine, University of Nairobi, Nairobi, Kenya PubMed articlesGoogle scholar articles
  • Stefanie W Benoit Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA Department of Pediatrics, University of Cincinnati, College of Medicine, Ohio, Cincinnati, USA PubMed articlesGoogle scholar articles
  • Fabian Sanchis-Gomar Department of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California, USA Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain PubMed articlesGoogle scholar articles
  • Giuseppe Lippi Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy PubMed articlesGoogle scholar articles
  • Justin Benoit Department of Emergency Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Brandon Michael Henry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; Brandon.henry{at}cchmc.org
View Full Text

Citation

Henry BM, Cheruiyot I, Benoit SW, et al
Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study
Journal of Clinical Pathology 2022;75:410-415.

Publication history

  • Received November 8, 2020
  • Revised February 21, 2021
  • Accepted February 24, 2021
  • First published March 31, 2021.
Online issue publication 
May 19, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage